Introducing the latest European Oncology & Haematology supplement on gastrointestinal oncology titled Optimising Clinical Outcomes in Gastrointestinal Cancers through Inhibiting Angiogenesis and Other Signalling Pathways.
Optimising Clinical Outcomes in Gastrointestinal Cancers through Inhibiting Angiogenesis and Other Signalling Pathways
The inhibition of angiogenesis and other signalling pathways has great potential in the treatment of various cancers including metastatic colorectal cancer (mCRC) and hepatocellular carcinoma (HCC). This approach is exploited by multikinase inhibitors (MKIs), which, when used in sequence with other chemotherapy agents, have shown to have efficacy with mostly manageable safety profiles although side […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!